Institutional members access full text with Ovid®

Share this article on:

Varicella-Related Primary Healthcare Visits, Hospitalizations and Mortality in Norway, 2008-2014.

Mirinaviciute, Grazina MPH; Kristensen, Erle MD; Nakstad, Britt MD, PhD; Flem, Elmira MD, PhD
Pediatric Infectious Disease Journal: Post Acceptance: June 27, 2017
doi: 10.1097/INF.0000000000001656
Original Studies: PDF Only

Background: Norway does not currently implement universal varicella vaccination in childhood. We aimed to characterize healthcare burden of varicella in Norway in the pre-vaccine era.

Methods: We linked individual patient data from different national registries to examine varicella vaccinations and varicella-coded primary care consultations, hospitalizations, outpatient hospital visits, deaths, and viral infections of central nervous system (CNS) in the whole population of Norway during 2008-2014. We estimated healthcare contact rates and described the epidemiology of medically attended varicella infection.

Results: Each year approximately 14, 600 varicella-related contacts occurred within primary healthcare and hospital sector in Norway. The annual contact rate was 221 cases per 100,000 population in primary healthcare and 7.3 cases per 100,000 in hospital care. Both in primary and hospital care, the highest incidences were observed among children one year of age: 2,654 and 78.1 cases per 100,000, respectively. The annual varicella mortality was estimated at 0.06 deaths per 100,000 and in-hospital case-fatality-rate at 0.3%. Very few (0.2%-0.5%) patients were vaccinated against varicella. Among hospitalized varicella patients, 22% had predisposing conditions, 9% had severe to very severe comorbidities and 5.5% were immunocompromised. Varicella-related complications were reported in 29.3% of hospitalized patients. Varicella-zoster virus was the third most frequent virus found among 16% of patients with confirmed viral infections of CNS.

Conclusions: Varicella causes a considerable healthcare burden in Norway, especially among children. To inform the policy decision on the use of varicella vaccination, a health economic assessment of vaccination and mathematical modeling of vaccination impact are needed.

Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.